Current position

Millennium Management LLC’s Eli Lilly (LLY) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Millennium Management LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2021Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares990.21KHighest verified quarter-end share count
Quarters reported18Verified quarters with shares above zero
What happened?

Millennium Management LLC first reported Eli Lilly in Q3 2021. The reported position was increased and reduced across later filings. Millennium Management LLC currently reports 182.68K shares. The latest verified filing showed: Sold 33.8% of the position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Sold 33.8% of the position−93.31K shares · 182.68K shares remained
Filing context

Quarter-end price $1,199.43

Q1 2026
Sold 17.6% of the position−58.87K shares · 275.99K shares remained
Filing context

Quarter-end price $919.77

Q4 2025
Bought 11.5% more+34.60K shares · 334.86K shares reported after the change
Filing context

Quarter-end price $1,074.68

Q3 2025
Sold 47.4% of the position−270.64K shares · 300.26K shares remained
Filing context

Quarter-end price $763.00

Q2 2025
Sold 16.2% of the position−110.12K shares · 570.89K shares remained
Filing context

Quarter-end price $779.53

Q1 2025
Sold 15.0% of the position−120.05K shares · 681.01K shares remained
Filing context

Quarter-end price $825.91

Portfolio importance

How important is Eli Lilly in Millennium Management LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.1%Q2 2026
Current rank#216of 5796 reported positions
Peak portfolio weight0.4%Q3 2024
Best historical rank#26Q3 2024
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$1,183.462026-09-25

Market context only; not an investor transaction price.

Latest filing quarter-end price$1,199.43Q2 2026

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

View Eli Lilly stock page →

This is a bounded selection from a 13F combination report. A portion is reported separately by another manager. The profile does not represent all investments, trades or performance. Quarters are reporting observations, not transaction dates.